High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.

High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.

Show other versions (1)
Bibliographic Details
Main Authors: Mitchell, S, Bansi, D, Hunt, N, Christie, J, Fleming, K, Chapman, R
Format: Journal article
Published: 1997

Similar Items